182 related articles for article (PubMed ID: 22918769)
21. Pitfall in follow-up imaging of pancreatic neuroendocrine tumor by somatostatin receptor PET.
Reindl O; Loidl A; Franz B; Hofer JF; Pichler R
Neuro Endocrinol Lett; 2013; 34(4):273-4. PubMed ID: 23803870
[TBL] [Abstract][Full Text] [Related]
22. Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.
Henze M; Schuhmacher J; Dimitrakopoulou-Strauss A; Strauss LG; Mäcke HR; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):466. PubMed ID: 14730407
[No Abstract] [Full Text] [Related]
23. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220
[TBL] [Abstract][Full Text] [Related]
24. Gallium-68 DOTATOC PET/CT in vivo characterization of somatostatin receptor expression in the prostate.
Todorović-Tirnanić MV; Gajić MM; Obradović VB; Baum RP
Cancer Biother Radiopharm; 2014 Apr; 29(3):108-15. PubMed ID: 24450327
[TBL] [Abstract][Full Text] [Related]
25. [Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations].
Hartmann H; Zöphel K; Freudenberg R; Oehme L; Andreeff M; Wunderlich G; Eisenhofer G; Kotzerke J
Nuklearmedizin; 2009; 48(5):201-7. PubMed ID: 19639164
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor-based PET/CT of intracranial tumors: a potential area of application for 68 Ga-DOTA peptides?
Sharma P; Mukherjee A; Bal C; Malhotra A; Kumar R
AJR Am J Roentgenol; 2013 Dec; 201(6):1340-7. PubMed ID: 24896203
[TBL] [Abstract][Full Text] [Related]
27. Impact of Tumor Burden on Quantitative [
Werner RA; Hänscheid H; Leal JP; Javadi MS; Higuchi T; Lodge MA; Buck AK; Pomper MG; Lapa C; Rowe SP
Mol Imaging Biol; 2019 Aug; 21(4):790-798. PubMed ID: 30406512
[TBL] [Abstract][Full Text] [Related]
28. Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.
Kaemmerer D; Peter L; Lupp A; Schulz S; Sänger J; Prasad V; Kulkarni H; Haugvik SP; Hommann M; Baum RP
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1659-68. PubMed ID: 21626438
[TBL] [Abstract][Full Text] [Related]
29. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.
Miederer M; Seidl S; Buck A; Scheidhauer K; Wester HJ; Schwaiger M; Perren A
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):48-52. PubMed ID: 18807033
[TBL] [Abstract][Full Text] [Related]
30. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
[TBL] [Abstract][Full Text] [Related]
31. In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass.
Velikyan I; Sundin A; Eriksson B; Lundqvist H; Sörensen J; Bergström M; Långström B
Nucl Med Biol; 2010 Apr; 37(3):265-75. PubMed ID: 20346866
[TBL] [Abstract][Full Text] [Related]
32. Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia.
Froeling V; Elgeti F; Maurer MH; Scheurig-Muenkler C; Beck A; Kroencke TJ; Pape UF; Hamm B; Brenner W; Schreiter NF
Ann Nucl Med; 2012 Nov; 26(9):738-43. PubMed ID: 22865406
[TBL] [Abstract][Full Text] [Related]
33. Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies.
Lincke T; Singer J; Kluge R; Sabri O; Paschke R
Thyroid; 2009 Apr; 19(4):381-9. PubMed ID: 19355828
[TBL] [Abstract][Full Text] [Related]
34. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
Kulkarni HR; Baum RP
PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
[TBL] [Abstract][Full Text] [Related]
35. Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC?
Öksüz MÖ; Winter L; Pfannenberg C; Reischl G; Müssig K; Bares R; Dittmann H
Diagn Interv Imaging; 2014 Mar; 95(3):289-300. PubMed ID: 24034971
[TBL] [Abstract][Full Text] [Related]
36. PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.
Sollini M; Erba PA; Fraternali A; Casali M; Di Paolo ML; Froio A; Frasoldati A; Versari A
ScientificWorldJournal; 2014; 2014():194123. PubMed ID: 24693229
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
38. Intrathoracic splenosis: a rare false-positive cause of somatostatin imaging in characterization of solitary pulmonary nodule.
Mahmoudian B; Javadrashid R; Fakhrjoo A
Clin Nucl Med; 2015 Feb; 40(2):138-40. PubMed ID: 25546186
[TBL] [Abstract][Full Text] [Related]
39. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
